Crinetics Pharmaceuticals, Inc. (CRNX)
47.40
+0.73
(+1.56%)
USD |
NASDAQ |
Dec 08, 16:00
47.41
+0.01
(+0.02%)
After-Hours: 20:00
Crinetics Pharmaceuticals Market Cap: 4.498B for Dec. 8, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 892.86B |
| Amgen, Inc. | 172.98B |
| Madrigal Pharmaceuticals, Inc. | 12.91B |
| United Therapeutics Corp. | 20.65B |
| NovaBay Pharmaceuticals, Inc. | 195.32M |
Market Cap Related Metrics
| PS Ratio | 2876.44 |
| PEG Ratio | -0.476 |
| Price to Book Value | 4.195 |
| Price | 47.40 |
| Earnings Yield | -9.57% |
| PEGY Ratio | -0.476 |